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Chapter 2




As described in the introduction, 5-(o-nitrobenzyl)selenyl-2-hydroxypentanoic
acid (NBSeOH) is designed to cleave the backbone of a protein site-specifically in real
time.  This ability allows an experimenter to probe many structure-function relationships
of a protein.  Figure 2.1 gives a good depiction of three different aspects of ion channel
function that could be explored using light-activated protein cleavage.
It is rather difficult to map the protein backbone conformational changes that
occur during opening and closing of a channel.  By incorporating a cleavable amino acid,
the function of a channel can be studied before and after photolysis. The technique can be
used to incorporate the cleavable amino acid and map the backbone positions where
conformational changes occur during the opening and closing of the channel. For
instance, the cleavable amino acid could be used to uncouple the binding of an agonist to
the opening of the channel.  In addition, the functional interactions of regulatory proteins
could be studied.  This could be done by creating a fusion protein of the ion channel to
the regulatory protein with the cleavable amino acid incorporated into the tether and
analyzing the function of the channel before and after photolysis.  The technique could
also be used to identify protein domains that are essential in function.  A photo-cleavable
amino acid allows one to proteolyze a protein site-specifically in vivo.
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Figure 2.1 Uses of a photo-cleavable amino acid  
1)  Distinguish where the conformational change occurs down the backbone of a protein. 
2) Study regulatory proteins by covalently linking them to the protein of interest and then 
    cleaving the tether. 






































































Representation of the nAChR with the backbone of the receptor thought to move during receptor opening 
(colored in red).  If this backbone was broken using a light-activated cleavable amino acid, the 
channel would not function 
Many ion channels are modulated by interactions with regulatory proteins.  The green ellipses are regulatory
proteins and the blue is an ion channel.  The channel's function can be tested bound and unbound to the tethered
regulatory protein. 
Schematic of the Shaker B ion channel.  The N-terminus ball is depicted as a circle.  The N-terminus is known
to inactivate the channel by blocking the pore.  If the N-terminus was clipped off the protein, inactivation 












































































Figure 2.2 Nitrophenylglycine (Npg)
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The first attempt to create a light-induced cleavable amino acid was the synthesis
of (2-nitrophenyl)glycine (Npg) (Figure 2.2) by Dr. Pam England (1).  Irradiation of Npg
leads to site-specific, nitrobenzyl-induced photochemical proteolysis (SNIPP).  The
amino acid is based on nitrobenzyl photochemistry. Nitrobenzyl and analogs of it are
used as protecting groups in organic synthesis, (2-5) and in biology they are used to
produce ‘caged’ agonists, antagonists, and second messengers that are liberated
photochemically (6-8).  Dr. England incorporated the amino acid Npg into the Shaker B
potassium channel and the nicotinic acetylcholine receptor in vivo and showed that
irradiation in vivo of the proteins led to SNIPP.
The Shaker B channel is a homotetrameric voltage activated K+ channel (Figure
2.1, Section C).  In this channel the N-terminus is known to inactivate the channel after
opening by blocking the pore of the channel on a millisecond time scale; this inactivation
is called N-type inactivation (9-12).  A “ball-and-chain” mechanism underlies N-type
inactivation.  The first 20 amino acids in the N-terminus form a structural domain or
“ball” region that is connected to the rest of the channel by a “chain” sequence of 60 or
more amino acids that tethers the inactivation ball to the rest of the protein.  Deletion of a
section of the N-terminus (D6-46) completely abolishes N-type inactivation.  Dr. England
showed that photolysis of the channel with Npg incorporated into the  N-terminus at sites
Leu 47 or Pro 64 in the channel decreases the N-type inactivation (1).  Photolysis of the
Npg containing channels leads to loss of the inactivation ball (N-terminus domain) of the
channel, which leads to reduction of inactivation.  It has been shown previously that only
a single ball is necessary for channel inactivation, therefore, because there are four
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independent balls in the channel the rate and extent of inactivation depends on the
number of balls that the channel contains.  Dr. England found that on average two of the
four balls from ShB channels were removed after a 4-hour irradiation (1).
The Npg work illustrates well the power cleavable amino acids can have.
However, there were several problems with Npg.   Probably due to the steric bulk at the b
carbon on Npg, the unnatural amino acid did not suppress well into ion channels (reduced
incorporation)(13).  In suppression experiments with Npg at the aV132TAG site in the
nicotinic acetylcholine receptor (nAChR), oocytes had to be injected three times before
electrophysiological recordings could be done.  In addition, for full cleavage to occur
oocytes had to be irradiated for four hours.  The long irradiation time reduced the utility
of Npg because oocytes could not be irradiated during an electrophysiology recording.
The NBSeOH work was initiated to try to find a molecule with more favorable
suppression properties and more rapid photolytic kinetics than Npg.
NBSeOH (Figure 2.3) is a hydroxy acid whose side chain contains a three carbon
tether and selenium that is protected with o-nitrobenzyl.  Upon irradiation, the o-
nitrobenzyl protecting group is photochemically removed to reveal a selenium anion.
The selenium anion then attacks the carbinol carbon and initiates an intramolecular SN2
displacement that cleaves the backbone ester.   Selenium anions are known to be strong
nucleophiles (14).  Selenium has been shown in many model experiments to attack the
carbinol carbon and break sterically bulky esters (15-18).  Selenocysteine is a naturally
occurring amino acid.  The pKA of selenocysteine is 5.73 (19); therefore, after photolysis
selenium should be in its anionic state.  In addition, large hydrophobic unnatural amino
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acids and hydroxy acids have been shown to suppress rather well with the nonsense
suppression technique (13, 20-22).  The b carbon on NBSeOH is not hindered.  Based on
all of the above reasons, it is believed that NBSeOH will suppress better and break the
peptide backbone quicker than Npg.
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2.2.1 NBSeOH and NVSeOH:
The synthetic scheme which now seems straightforward took several
iterations before the molecule was finally isolated (Figure 2.4).  Some of the initial
pathways that were used to obtain the molecule are discussed in the appendix.  The final
synthetic route is shown in Figure 2.4.  The route begins by the conversion of d-
valerlactone to 2-hydroxy d-valerlactone using the method described in (23).  The lactone
was then opened using 30% HBr in acetic acid (24, 25).  The brominated product was
then reacted with sodium diselenide to synthesize the 2-hydroxypropylethyl ester
diselenide according to literature protocol (26).  The diselenide was reduced with sodium
borohydride, which revealed a selenium anion that was reacted with o-nitrobenzyl
bromide (27, 28).   The ethyl ester protecting group was removed and the carboxylic acid
was activated using chloroacetonitirile and ligated to dCA as described in (29-31).
In addition, the nitroveratryl version of NBSeOH or 5-(4,5-dimethoxy-2-
nitrobenzyl)selenyl-2-hydroxypentanoic acid (NVSeOH) was synthesized.  The synthetic
route described above was used except during the reduction of the diselenide 4,5-
dimethoxy-2-nitrobenzyl bromide was used.  NVSeOH was also ligated to dCA but has
not been as extensively tested as NBSeOH.
All products were characterized by NMR and mass spectrometry.  Selenium
compounds have a nice diagnostic pattern in mass spectrometry.  The isotopic masses for
selenium are 79.9 (100%), 77.9 (47.9%), 75.9 (18.9%), 81.9 (17.6%), and 76.9 (15.4%).
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Therefore, it is very easy to visualize the isotopic pattern of selenium in a mass spectrum.
This was used quite often to visualize if the crude material did contain product.  The
experimental section contains all NMR and mass spectra, and in many of the selenium
containing compounds the isotopic pattern found in the mass spectrum is listed.
2.2.2 Peptide synthesis:
Initially, a synthetic scheme was derived to synthesize a tripeptide (Phe-
NBSeOH-Glu) that could then be used in cleavage studies.  We thought that a peptide
would be easier to handle than a full protein to study if NBSeOH did indeed cleave an
ester after photolysis.  NMR and mass spectrometry analysis would reveal if NBSeOH
was cleaving.  The synthetic scheme for the tripeptide is shown below (Figure 2.5). The
synthesis was never carried out any further than the phenylalanine coupling because the
yield of the tert-butylation synthetic step was low.
N,N-dimethylformamide di-tert-butyl acetal was used to esterify the carboxylic
acid of NBSeOH (Figure 2.5, Route A).  This reagent allows tert-butylation to occur only
on the carboxylic acid and not the alcohol (32).  Ditertbutyldicarbonate (BOC2O) with a
catalytic amount of dimethylaminopyridine was used initially but was found to protect
both the alcohol and the carboxylic ester (33).   However, the N,N-dimethylformamide
di-tert-butyl acetal reaction gave a significant amount of selenium eliminated product (2-
hydroxy-pent-4-enoic acid tert-butyl ester), and this side reaction significantly reduced























2) di-tert-butyl glutamate,DCC, DMAP, CH2Cl2 





































1) 4.67 Na2CO3, 5 NaBH4, DMF






Synthesis of peptide with either N,N'-dimethylformamide di-tert-butyl acetal (Route A)
or  dimethylboron bromide (Route B).
                                                   Figure 2.5 
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In the N,N-dimethylformamide di-tert-butyl acetal reaction a large excess (4
equivalents) of the reagent is used because the tert-butyl carbocation that forms in the
reaction can either react with the carboxylic acid on NBSeOH or can lose a proton and
form 2-methyl-2-propene (32).  However, in the present system the selenium could also
be alkylated by the tert-butyl cation, which then leads to the selenium eliminated product
(2-hydroxy-pent-4-enoic acid tert-butyl ester) (34).  The reaction was done in both
refluxing toluene and at room temperature. The eliminated product was still a major
product in the reaction when it was run at room temperature.  The reaction has never been
performed with just one or two equivalents of N,N-dimethylformamide di-tert-butyl
acetal; using a smaller excess of the reagent might prevent the elimination of the
selenium in the desired product but will probably reduce the yield of the reaction.  The
new synthetic route (B) in Figure 2.5 protects the carboxylic acid early in the synthesis
and eliminates the N,N-dimethylformamide di-tert-butyl acetal reaction.
The protected NBSeOH was then coupled to N-acetyl protected phenylalanine
using 1,3-dicyclohexylcarbodiimide and a catalytic amount of dimethylaminopyridine
(35).  Three milligrams of the dipeptide was synthesized.  The dipeptide was used in a
photolysis NMR experiment.  The products of the photolysis were isolated using Prep-
TLC and analyzed by a mass spectrometer.  This experiment will be discussed in the
results section.
A new synthetic route has been designed to synthesize tert-butyl NBSeOH
(Figure 2.5, Route B).  This synthetic route starts with (S)-oxotetrahydrofuran 2-
carboxylic acid.  The carboxylic acid is protected with ditertbutyldicarbonate (BOC2O)
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and the furan ring is opened with dimethylboron bromide (33, 36).  The rest of the
synthesis is similar to the synthetic scheme in Figure 2.4.  I have synthesized 5-
oxotetrahydrofuran 2-carboxylic acid tert-butyl ester in a prior synthetic route (See
Appendix).  The reaction goes in a 91% yield and several grams of the product have been
synthesized.  The rest of the synthesis will be carried out by another member of the
Dougherty group.  Hopefully with this new synthetic route, the tripeptide can be
synthesized efficiently.
2.3 Results:
2.3.1 Dipeptide model system:
A dipeptide containing phenylalanine and NBSeOH was synthesized using
routine solution phase peptide coupling reactions.  Due to the low yield of the tert-
butylation, the final amount of dipeptide synthesized was approximately 3 milligrams.
The peptide was dissolved in 400 ml of deuterated acetonitrile and used in NMR studies.
Argon was bubbled through the sample for several minutes before the sample was
capped.  The NMR tube was placed such that the beam of light from the arc lamp
encompassed the whole four inches of the sample.  The arc lamp was filtered to transmit
330-370 nm light with maximum intensity at 350 nm.  The sample was irradiated for 30s
and then for four one-minute time points, consecutively.  After each time point, an NMR


































Theoretical isotopic pattern 
238 (17.6%) 237 (10%) 236 (100%) 235 (5.1%) 234 (47.9%) 233 (15.4%)
Experimental values 
238 (13%) 237 (42%) 236 (100%) 235 (65%) 234 (65%) 233 (41%)
Table 2.1
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           When NBSeOH is deprotected, the nitrobenzyl protecting group forms
nitrosobenzylaldehyde (Figure 2.6).  An aldehyde peak at 10.15 ppm begins to emerge in
the spectra after 2.5 minutes.  In addition, the benzyl peak at 4.1 ppm begins to change
form and diminishes in size.  However, an internal standard was not used in the sample,
and therefore the exact difference in integration of peaks between different time points is
hard to evaluate.  After the last time point, Prep-TLC was used to separate the products of
the photolysis.  Three ultraviolet active bands were seen at Rfs of 0.56 (band 1), 0.77
(band 2), and baseline (band 3).  Bands were cut out of the plate, and the products
extracted out of the silica with ethyl acetate.
All three products were run on both the electrospray (ESI) mass spectrometer and
gas chromatograph – mass spectrometer (GC-MS).  Band 1 had a mass value of  206 [M-
H]-.  This mass value corresponds to N-acetyl-phenylalanine, which would arise if
cleavage of the ester occurred.  Band 2 when injected onto the GC-MS produced a broad
peak from 16.50-20 minutes.  The major area of the peak between 17.5-19 minutes gave
mass to charge ratios of 236, 252, and 264. The 236 mass corresponds to the selenium
product that occurs when the ester in the peptide is broken (Figure 2.6).  The 252 mass is
(236 + 16) and 264 mass is (236 + 18), which could correspond to an added oxygen or
water on the molecule.  All three masses have n-2 and n+2 peaks, which correspond to a
selenium isotopic pattern.  However, the isotopic ratios found in the 236 mass do not
completely match the theoretical isotopic pattern for the molecule (Table 2.1).  While the
origin of the large M+1 and M-1 peaks is unexplained at present, large M-2 and M+2
27
peaks are not seen in the GC-MS spectra of molecules not containing selenium.  No mass
spectral peaks were seen with the baseline band (3) using electrospray or the GC-MS.
These preliminary results are very promising, and it definitely seems like photolysis and
cleavage are occurring.  However, the experiment should be done again with a larger
quantity of material.  In addition, an internal standard should be included in the sample
(either pentachloroethane that has singlet at 6.39 ppm or tetrachloroethane that has a
singlet at 6.08 ppm).   With the new synthetic scheme using dimethylboron bromide,
more material should be able to be synthesized.
 2.3.2 In vitro protein incorporation – base hydrolysis:
A quick and easy technique to visualize if an unnatural amino acid is
translationally competent and is incorporating into a protein is through in vitro
transcription. Rabbit reticulocyte lysate was used to in vitro transcribe mRNA coding for
nAChR aL250TAG subunit.  This construct also contained an HA epitope between
residues 347-348.  The HA epitope is an antigenic peptide (YPYDVPDYA) derived from
hemagglutinin (38, 39).  This epitope was used to visualize the protein on a Western blot
using antibodies against the HA sequence.  Full length protein was found in lanes
containing mRNA and NBSeOH charged tRNA.  No protein was seen in lanes for which
the transcription mix contained mRNA only or mRNA with uncharged tRNA (labeled
dCA control) (blot 2.2).
Hydroxy acids form ester bonds when incorporated into proteins.  The ester
linkage can be hydrolyzed using concentrated base and the cleaved product may be
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observed on a Western blot (20).  Blot 2.1 is a Western blot of nAChR a subunit
suppressed with Leu, a-hydroxy valine (Vah), NBSeOH, and NVSeOH.  The arrow
indicates the cleaved product band, which is observed only in the Vah and NBSeOH base
treated lanes.  In blot 2.1, the NVSeOH base treated lane is not shown because the sample
was poorly loaded in that lane.  However, NVSeOH has been shown to cleave under base
hydrolysis conditions when incorporated into the a 247 TAG mRNA construct (data not
shown).  Western blot 2.1 verifies that NBSeOH and NVSeOH are tolerated by the
ribosome and are being incorporated into the protein.  Based on relative intensities of the
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In vitro suppression in the α subunit at position 250, protein contains the HA epitope. Samples were
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In vitro suppression in α subunit, containing the HA epitope and seven histidines tag, at position
247.  Protein was purified using Ni2+ beads and eluded using 300 mM imidazole.  The samples were




2.3.3 In vitro protein incorporation – photolysis experiments:
The ability of NBSeOH to photochemically cleave the protein backbone was also
analyzed using in vitro transcribed protein.  NBSeOH was suppressed in the a subunit of
the nAChR at position 247 using rabbit reticulocyte lysate.  This construct also contained
the HA epitope.  Western blot analysis was used to view the protein.  If cleavage of the
ester does occur after photolysis, a band corresponding to 24 kDa will be seen.  This
protein fragment will contain the amino acids from 247 on to the end of the protein
(including the HA epitope).  In addition, if transcription stopped at the UAG codon at
position 247 the protein fragment would not be seen on the Western blot because the HA
epitope is between positions 347-348.
Photolysis experiments were first tried on protein in the rabbit reticulocyte lysate
mix. Sample treatment can be found in the methods section.  Samples were irradiated for
ten minutes using our standard procedure (31, 40).  No cleavage bands were seen on the
gel. Rabbit reticulocyte lysate is a dark red color due to the high quantity of heme in the
lysate.  There was concern that the lysate was absorbing much of the light, and
effectively abrogating photolysis of NBSeOH.
Based on the photolysis experiments, His tag purification was performed to
remove the a subunit from the lysate mix after transcription.  Seven histidines were
cloned into the C-terminus of the a HA 247 TAG construct.  The polyhistidine tag is
used to isolate protein using Ni2+ agarose beads (41-43).  Protein is removed from the
beads using a high concentration of imidazole.  In my procedure, a 300 mM imidazole
concentration was used to elude protein off the beads.  Photolysis experiments were
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performed with protein in the 300 mM imidazole solution (Blot 2.3).  As can be seen in
the Western blot, protein seems to disappear after being exposed to light (no matter what
amino acid was suppressed).  I believe the high concentrations of imidazole in the
samples resulted in aggregation and/or degradation of the protein during the irradiation.
Consequently, imidazole must be removed before the photolysis experiments can be
performed.
There are many ways to remove small molecules from a protein sample.  Often
dialysis is used to remove salts.  However, because my samples are very small (ª 150 ml),
dialysis is a rather tricky process. Instead of dialysis, a spin column containing a semi-
permeable membrane (molecules > 30 kDa retained) from Millipore was used.  The
imidazole samples were concentrated and the imidazole removed using the spin-filter
columns.  The purified protein was then used in photolysis experiments.  Several
photolysis experiments were run, but the photolytic fragment was seen in only one
experiment (data not shown).
The photolysis in vitro experiments have not been as convincing as the base
hydrolysis experiments.  Often a non-specific band is seen around 24 kDa on Western
blots of the transcribed a protein; and therefore, it is difficult to distinguish if the band is
due to photolysis or is the non-specific band.  The non-specific band is seen in dCA
control and mRNA only translation reactions; therefore, it is not thought to be due
specifically with the a protein.  However, the band does get darker when a protein is
expressed in the reaction.   Another position closer to the N-terminus of the protein than
247 could be used for suppression experiments, allowing a larger cleavage product to be
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produced upon photolysis.  For instance, a band around 35 kDa would be easier to
recognize (no non-specific bands).  However, a nice method for purification using Ni2+
beads and a spin-filter has been developed, and hopefully, using this method, a Western
blot of photo-cleaved protein can be obtained.
2.3.4 In vivo protein incorporation:
NBSeOH has been incorporated into the Shaker B potassium channel.  When the
channel opens due to depolarization, potassium ions flow out of the cell through the
channel.  By convention, this current is illustrated has a positive current.  One of the
characteristics of this voltage-gated channel is rapid (N-type) inactivation which results
from the N-terminal portion of the receptor blocking the open pore (9-12).  This
inactivation can be seen in Figure 2.7 (before photolysis trace).  The current decreases in
milliseconds after opening of the channel.  Previous experiments have shown that
removal of the N-terminus of the receptor produces a channel that does not inactivate.
Using in vivo nonsense suppression, NBSeOH, Leu, and Npg were introduced into the N-
terminus at position 47 in the Shaker B potassium channel.  This is the same position that
Pam England used in her Npg study (1).  Suppression efficiency with NBSeOH was quite
good, and importantly, was roughly 10-fold greater than with Npg.
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Electrophysiology traces of ShBL47TAG mutants with NBSeOH incorporated.  Oocytes are irradiated with light 
for one minute on electrophysiology rig, before the second trace is taken (after photolysis trace).
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(Amplitude of current ≈ 35 ms after Voltage Jump)
(Maximum Amplitude of Current) X 100
% of Inactivating current = 100 - % of Noninactivating Current




Experiments were done on a two-electrode voltage-clamp oocyte rig equipped with
a flash lamp that is connected to the bath of the rig with a liquid light guide (Figure 2.7A)
(44).  When the shutter is open the oocyte is bathed in light.  As shown in Figure 2.7B, one
minute of photolysis leads to a high percentage of noninactivating current (or reduction of
inactivating current). Preliminary analysis suggests that on average the percent of
noninactivating current is 35 + 3% in Shaker B channels suppressing NBSeOH after a one
minute photolysis. However, some oocytes suppressing NBSeOH show higher percent of
noninactivating current.  Figure 2.7B is a trace of an oocyte suppressed with NBSeOH that
has a  50% increase in the noninactivating current.  Figure 2.7C illustrates the calculations
that are used in analyzing the data.  In the England paper, 27% noninactivating current is
seen after a 4-hr photolysis in Shaker channels suppressing Npg (1).
2.4 Discussion and conclusions:
As revealed by the in vitro work, NBSeOH can be incorporated into the a subunit
of the nAChR at positions 250 and 247 using nonsense suppression.  Efficiency of
incorporation is lower than leucine and hydroxy-valine.  This is probably due to the steric
bulk of the hydroxy acid. However, in vitro incorporation of NBSeOH is better than Npg
(data not shown).   Base hydrolysis experiments unambiguously confirm the suppression
with NBSeOH.
The preliminary dipeptide results reveal that the o-nitrobenzyl protecting group
begins to be removed in 2.5 minutes (when the aldehyde peak emerges).  In addition,
35
after 4.5 minutes, two products can be isolated from the photolysis reaction.  The
products have mass values corresponding to N-acetyl-Phe and tetrahydroselenophen-2-
carboxylic acid tert-butyl ester, both of which would be created if the ester bond were
cleaved.  With the newly designed synthetic route B, the tripeptide study should be
possible.  The tripeptide study will hopefully confirm the preliminary dipeptide results.
The in vivo ShB experiments have also shown NBSeOH to be incorporated into a
protein and to cleave a protein more efficiently than Npg.  NBSeOH has been shown to
cleave an ester when incorporated into the ShB channel in a one-minute irradiation.
Comparable cleavage with Npg requires four-hour irradiation.  However, it should be
noted that Pam England used a different photolysis setup than the one used in these
experiments (1).  While more work remains to be done, these early studies indicate that
1) NBSeOH can be synthesized and efficiently incorporated into proteins expressed in
vitro and in vivo 2) photolysis of peptides or proteins containing NBSeOH does lead to
backbone cleavage 3) in terms of suppression and photochemical efficiency, NBSeOH
represents a significant improvement over Npg.
2.5 Methods:
2.5.1 Synthesis:
Reagents were purchased from Aldrich, Sigma, or other commercial sources. All
bought chemicals were used without purification except d-valerlactone, which was
purified by distillation under vacuum at (bp 58-60oC/0.5 mm Hg).  Anhydrous solvents
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were purchased from Mallinkrot Baker; anhydrous DMF was obtained from Fluka. Flash
chromatography was done on 230-400 mesh silica gel with the solvent indicated.  All
NMR shifts are reported as d ppm downfield from TMS. 1H NMR and 13C spectra were
recorded using a GE QE-300 MHz spectrometer.  Electrospray (ESI) ionization,
quadrupole mass spectrometry was performed at the Caltech Protein/Peptide Micro
Analytical Laboratory. Gas chromatography – mass spectrometry (GC-MS) was
performed at Caltech mass spectrometry laboratory.  High performance liquid
chromatography (HPLC) separations were performed on a Waters dual 510 pump liquid
chromatography system equipped with a Waters 490E variable wavelength UV detector.
Semi-preparative samples were separated using a Whatman Magnum 9 column (9.4 x
500 mm, Partisil 10, ODS-3).
Synthesis of NBSeOH
2-hydroxy d-valerlactone  (A) – To a 25 ml round bottom with a condensor was added 3
ml of purified d-valerlactone (32.3 mmol) and 0.34 ml of phosphorous tribromide (3.56
mmol) via syringe. The mixture was heated in an oil bath to 100oC.  The reaction was
kept at this temperature for 10 minutes before 2.1 ml of bromine (40.4 mmol) was slowly
added to the reaction via syringe.  The reaction was kept under argon throughout the
reaction.  After complete addition of bromine, the reaction was heated to 120oC for an
hour and a half.  The oil bath was then turned off and the reaction was opened to air to
allow the removal of any excess bromine gas before quenching the reaction.   The
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reaction was then transferred to a 250 ml round bottom and 53.8 ml of water was added.
The solution was then refluxed for two days.  The solvent was then removed under
vacuum.  The dark brown oil, which remained after the solvent was removed, was then
transferred to a 25 ml round bottom and product was purified using a Kugelrohr (99-
101oC, 0.8 mm Hg).  After 3 hours, pure product was removed from the distillation bulbs.
Yield: 62%. 1H NMR (CD2Cl2) d 10.9 (broad s, 1H), 4.45 (AB, J = 5.7, 3 Hz, 1H), 3.87
(m, 2H), 2.24 (m, 1H), 2.03 (m, 1H), 1.91 (m, 2H)  13C (CD2Cl2) d 177.3, 77.0, 70.2, 30.7,
25.9
2-hydroxy-4-bromopropylethyl ester (B) -  In a 25 ml round bottom charged with product
A (650 mg, 5.60 mmol), 1.67 ml of 30% HBr in acetic acid was slowly added via syringe.
The reaction was heated to 70oC for 12 hours.  Then 6 ml of dry EtOH was added to the
reaction.  The reaction was heated another 12 hours at 70oC.  The reaction was quenched
by adding several cubes of ice and 6 ml of saturated sodium bicarbonate solution.  The
product was extracted out of the aqueous solution using 3 X 15 ml of ether.  The organic
layers were combined, dried over MgSO4, and decanted into a round bottom flask.  The
solvent was removed by vacuum and a 15 mm flash column was run in 60:40 ethyl
acetate to hexane solvent system.   Product is visualized on thin layer chromatography
plates using KMnO4 staining. Yield: 43%.  1H NMR (CD2Cl2) d   1.30 (t, J = 7.2, 3H),
1.80 (m, 4H),  3.42 (m, 2H), 4.12 (m, 1H), 4.24 (q, J=7.2, 2H) 13C NMR (CD2Cl2)
d 174.9, 70.0, 62.1, 33.9, 33.1, 28.7, 14.3
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2-hydroxypropylethyl ester diselenide (C)  – In a 25 ml round bottom,  elemental
selenium (137 mg 1.73 mmol),  NaBH4 (131 mg, 3.45 mmol), and 10 ml of water were
added.  Elemental selenium was measured in a ventilated chemical hood.  Elemental
selenium is highly toxic and is easily taken up by the lungs.  After 10 minutes, another
137 mg of elemental selenium was added to the reaction.   The reaction was then slightly
heated over a steam bath.  After 7 minutes, the solution turned a dark brown which is
indicative of Na2Se2 formation.   Product B (773 mg) was dissolved in 4 ml of a 1:1
mixture of THF and water; the solution was added to the reaction.  The reaction was
stirred at room temperature overnight.  The  reaction was worked up with 4 ml of 1 N
acetic acid and 10 ml of water.  Product was extracted out of the aqueous solution with 4
X 10 ml CH2Cl2.  The organic layers were combined, dried over MgSO4, and decanted
into a round bottom flask.  The solvent was removed by rotary-evaporation.  The product
was used in this crude form in the further reactions.  Product was rather unstable.  After
two weeks of storage, red elemental selenium began forming in the product.  However,
diselenide was purified for analytical analysis by flash chromatography using a 40:60
ethyl acetate and hexane solvent system.  Yield:  91% 1H (CD2Cl2) d   4.19 (q, J = 7.2,
4H), 4.16 (m, 2H), 2.93 (m, 4H), 1.86 (m, 8H), 1.26 (t, J = 7.2, 6H).  13C (CD2Cl2) d
175.57, 70.53, 62.28, 34.56, 29.91, 26.91, 14.57. FAB-MS: for C14H26O6Se2 [M-]
calculated 451.0138,  found [M-] 451.0152.
ethyl 5-(o-nitrobenzyl)selenyl-2-hydroxypentanoate (D) – Diselenide product C (48.6
mg, 0.11 mmol), Na2CO3 (54.4 mg, 0.51 mmol), NaBH4 (20.8 mg, 0.55 mmol), and 1.5
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ml of anhydrous DMF were added to a 5 ml round bottom.  The reaction was stirred at
room temperature for 1 hour.  The solution became light yellow over time.
Nitrobenzylbromide (99.8 mg, 0.46 mmol) dissolved in 0.5 ml of anhydrous DMF was
added to the reaction.  The reaction was kept in the dark and stirred at room temperature
overnight.  The reaction was quenched with 2 ml of 1 N acetic acid and 7 ml of water.
The product was extracted out of the aqueous solution using 2 X 10 ml ether.  Solvent
was removed by rotary-evaporation and high vacuum.  A flash column was run using
40:60 ethyl acetate and hexane solution. Yield: 49%. 1H (CD2Cl2) d 7.96 (m, 1H), 7.52
(m, 1H), 7.37 (m, 2H), 4.18 (q, J = 7.2 Hz, 2H), 4.06 (m, 1H), 4.08 (s, 2H) 2.58 (m, 2H),
1.60 (m, 4H), 1.25 (t, J = 7.2 Hz, 3H) FAB-MS: for C14H19NO5Se [M-] calculated
362.0507, found 362.0498
5-(o-nitrobenzyl)selenyl-2-hydroxypentanoic  acid (E) – One milliliter of 15% NaOH
solution and 0.5 ml of DMF were added to product D (39.2 mg, 0.11 mmol).  The
reaction was stirred for 6 hours.  The reaction was quenched with 8 ml of 6 N HCl, and
the product was extracted using 3 X 10 ml of ether.  The organic layers were combined,
dried over MgSO4, decanted, and solvent was removed using rotary evaporation. Used
without further purification.  Crude yield: 92%.  EIS-MS: for  C12H15NO5Se [M-]
calculated  333.0 (100%), 359.0 (48%), 335.0 (17.7%); found [M-H]-  332.2 (100%),
330.0 (74%), 334.0 (18%)
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5-(o-nitrobenzyl)selenyl-2-hydroxypentanoic acid cyanomethyl ester (F) – In the same
round bottom containing selenide E (33.2 mg, 0.1 mmol), 1 ml of dry ClCH2CN, 1 ml
anhydrous DMF, and 37 ml (0.26 mmol) of dry triethylamine were added.  The reaction
was stirred for 36 hours.  Then 15 ml of ether was added to the reaction, and the solution
was washed with 7 ml of water.   The organic layer was separated from the aqueous and
the solvent removed by rotary-evaporation and high vacuum.  Crude yield 69%. 1H
(CD3CN) d  7.85 (m, 1H), 7.60 (m, 1H), 7.45 (m,2H), 4.80 (s, 2H), 4.41 (s, 1.3H,
ClCH2CN), 4.08 (s, 2H), 4.07 (m, 1H), 3.44 (q, ether), 2.56 (m, 2H), 1.70 (m, 4H), 1.30
(m, ether)  EIS-MS: for  C14H16N2O5Se [M-Cl]- calculated is 407.0 (100%), 405.0 (46.9%)
, 409.0 (43.2%); found [M-Cl]- 407.2 (100%), 405.2 (46.3%), 409.2 (45.1%)
5-(o-nitrobenzyl)selenyl-2-hydroxypentanoyl-dCA (G) – The cyanomethyl ester product
F (12.75 mg, 35.8 mM) was coupled to the dinucleotide according to standard protocol
(29, 30).  In an oven-dried 5 ml conical flask with stir bar, cyanomethyl ester product F,
tetra-n-butyl-ammonium salt of the dCA dinucleotide (14.4 mg, 11.9 mmol), and 0.25 ml
of anhydrous DMF were added.  After several hours, a catalytic amount of dry
tetrabutylammonium acetate was added to the reaction.  The reaction was stirred
overnight.  The crude product was purified by reverse-phase semi-preparative HPLC with
a gradient from 25 mM NH4OAc (pH 4.5) to CH3CN.  The desired fractions containing
the hydroxy acid dinucleotide were combined, frozen, and lyophilized. The lyophilized
solid was redissolved in 10 mM aqueous acetic acid/acetonitrile and lyophilized a second
time to remove salts. The products were quantified by UV/Vis spectra and characterized
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by mass spectrometry.  EIS-MS: for  C31H38N9O17P2Se [M-] calculated is 950.09, found
[M-H]- 950.2
Synthesis of  peptide containing NBSeOH
t-butyl-5-(o-nitrobenzyl)selenyl-2-hydroxypentanoate (L) – To an oven dried 10 ml flask
containing selenide E (70 mg, 0.21 mmol), 1 ml of toluene was added, and the reaction
mixture was heated to 110oC in an oil bath.  When the oil bath reached 110oC, 0.24 ml of
N,N-dimethylformamide di-tert-butylacetal (0.84 mmol) was added to the reaction via
syringe. The reaction was allowed to reflux for one and half hours.  The reaction was then
quenched with 14 ml of water and product was extracted out with one wash of 30 ml of
ether and another wash of 10 ml of ether.  The organic layers were combined and washed
2 X 10 ml of sodium bicarbonate.  The organic layer was then dried over MgSO4,
decanted, and the solvent was removed by rotary-evaporation.  A 15 mm column using
40:60 ethyl acetate to hexane solvent system was used.  1H (CD2Cl2) d  7.96 (m, 1H), 7.55
(m, 1H), 7.4 (m,2H), 4.23 (q, ethyl acetate), 4.09 (s, 2H), 4.07 (m, 1H), 2.57 (m, 2H),
2.11 (s, water), 2.00 (s, ethyl acetate), 1.53 (s, 9H), 1.20 (m, ethyl acetate). EIS-MS: for
C16H23NO5Se [M-] calculated is 389.1, found [M-Na]+ 412.0.
Aceytl-NH-Phe-NBSeO-tert-butyl ester (M)  –  In a 5 ml conical flask containing ª 52
mg of product L (0.13 mmol),  Aceytl-NH-PheCOOH (27.8 mg, 0.13 mmol), DCC (41.5
mg, 0.20 mmol), and  DMAP (6.5 mg, 0.05 mmol) were added.  One milliliter of dry
methylene chloride was added to the reaction vessel.  The reaction was stirred in the dark
42
for two days.  The reaction was then brought up in 25 ml of ethyl acetate.  The reaction
mixture was gravity filtered.  The effluent was then washed with 5 ml of sodium
bicarbonate and 5 ml of salt solution. The solvent was then removed using rotary-
evaporation and high vaccum.  A flash column was run on crude material using a 60:40
ethyl acetate to hexane solvent system.  1H (CD2Cl2) d  7.99 (m, 1 H), 7.55 (m, 1H), 7.39
(m, 2H), 7.25 (m, 5H), 4.92 (m, 2H), 4.10 (s, 2H), 3.10 (m, 1H), 3.48 (m, 1H), 2.58 (m,
2H), 1.99 (s, 1.5H), 1.95 (s,1.5H), 1.65 (m, 4H), 1.49 (s, 4.5 H), 1.45 (s, 4.5 H), 1.1-1.4
(m – residual hexanes) FAB-MS: for C27H35N3O7Se [M+] calculated is 579.1609, found
579.1596.
Synthesis of  dCA-NVSeOH
ethyl 5-(4,5-dimethoxy-2-nitrobenzyl)selenyl-2-hydroxypentanoate (H) –To 193 mg
(0.43 mmol) of diselenide C, 213 mg (2.01 mmol) of sodium bicarbonate, 81.7 mg (2.16
mmol) NaBH4, and 5 ml of anhydrous DMF were added.  The reaction was allowed to
stir for 1.5 hours.  The solution turned from a dark yellow to a light yellow during the 1.5
hours.   Then 500 mg (1.8 mmol) of 4,5-dimethoxy-2-nitrobenzylbromide was dissolved
in 2 ml of anhydrous DMF and added to the reaction vessel.  The reaction was stirred at
room temperature for two days.  The reaction was quenched with 8 ml of 1 N acetic acid
and 20 ml of water.  The product was extracted out of the aqueous solution using 4 X 40
ml of ether.  The organic layers were combined and dried over Na2SO4 and decanted into
a dry round bottom.  The solvent was then removed by rotary evaporation and high
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vacuum.  Flash chromatography was performed using 50:50 ethyl acetate to hexane
solvent system.  Yield: 64%.  1H NMR (CD2Cl2) d 7.64 (s, 1H), 6.78, (s, 1H), 4.24 (m,
2H), 4.12 (s, 2H), 4.08 (m, 1H) , 3.94 (s, 3H), 3.90 (s, 3H), 2.60 (m, 2H), 1.80 (m, 4H),
1.30 (m, 3H). 13C NMR (CD2Cl2) d 113.56, 109.14, 70.36, 62.23, 56.87, 56.77, 34.96,
26.45, 25.26, 24.70, 14.59.
5-(4,5-dimethoxy-2-nitrobenzyl)selenyl-2-hydroxypentanoic acid (I) – Product H (216
mg, 0.55 mmol) was dissolved in 5 ml of 15% NaOH aqueous solution and 2.5 ml of
DMF.  The solution was stirred for six hours at room temperature.  Reaction was kept in
the dark the whole time.  The reaction was quenched with 6 N HCl until pH reached ª
3.6.  The product was extracted out of the aqueous solution with 3 X 30 ml of ether.  The
organic layers were combined, dried over MgSO4.  Solvent was removed by rotary
evaporation. Crude Yeild: 70%. EIS-MS: for C14H18NO7Se [M-] calculated is 393.03
(100%), 394.03 (48.0%); found [M-H]-  392.0 (100%), 393.2 (45.3%)
5-(4,5-dimethoxy-2-nitrobenzyl)selenyl-2-hydroxypentanyl cyanomethyl  ester (J) – To
an oven dried 5 ml conical flask with 66.2 mg (0.17 mmol) product I, 1 ml of
chloroacetonitrile, 1 ml of anhydrous DMF, and 73.3 ml of triethylamine were added.
The reaction was stirred for 36 hours.  The reaction was brought up in 20 ml of ether and
10 ml of water.  Product was extracted out with another 15 ml of ether.  Ether layers were
combined and concentrated by rotary-evaporation and high vacuum. Flash
chromatography was done using ethyl acetate as the solvent system Yield:  60.8 mg,
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83%.  1H NMR (CD2Cl2) d 7.62 (s, 1H), 6.77, (s, 1H), 4.82 (s, 2H), 4.11 (s, 2H), 4.09 (m,
1H), 3.92 (s, 3H), 3.89 (s, 3H),  3.88 (m, 2H), 2.90 (m,. 1H), 2.60 (m, 1
H), 1.80 (m, 4H). 13C NMR (CD2Cl2) d 113.6, 109.1, 70.4, 56.9, 56.8, 49.7, 43.6, 26.2,
25.3, 24.5.  EIS-MS: for C16H20N2O7Se [M-] calculated is 432.0, found [M-H]+ 433.0 and
[M-Na]+ 455.0
5-(4,5-dimethoxy-2-nitrobenzyl)selenyl-2-hydroxypentanoyl-dCA (K) – A 10 ml round
bottom was charged with 14.1 mg (0.012 mmol) of dCA and 15 mg (0.35 mmol) of
product J.  Anhydrous DMF (500 ml) was added to the reaction vessel.  The reaction was
stirred for an hour and a half.  No product was seen by analytical HPLC.  Therefore, a
catalytic amount of tetrabutylammonium acetate was added to the reaction.  The reaction
was allowed to stir overnight. The crude product was purified by reverse-phase semi-
preparative HPLC with a gradient from 25 mM NH4OAc (pH 4.5) to CH3CN.  The
desired fractions containing the hydroxy acid dinucleotide were combined, frozen, and
lyophilized. The lyophilized solid was redissolved in 10 mM aqueous acetic
acid/acetonitrile and lyophilized a second time to remove salts. The products were
quantified by UV/Vis spectra and characterized by mass spectrometry.  EIS-MS:  [M-]




Approximately 3 milligrams of Aceytl-NH-Phe-NBSeO-tert-butyl (M) described
above were dissolved in 400 ml of deudrated acetonitrile.  The solution was transferred to
an NMR tube.  Argon was bubbled through the sample for several minutes.  The sample
was capped and the top was wrapped with parafilm to seal the tube.  All 1H NMR spectra
were taken on the Varian 500 MHz spectrometer.  An initial 1H NMR was taken before
photolysis.  Then, the NMR tube was placed such that the beam of light from the arc
lamp (1000 W xenon arc lamp (Oriel) operating at 400 W equipped with WG-335 and
UG-11 filters) encompassed the whole four inches of the sample.  The sample was
irradiated for 30s and then for four one minute time points, consecutively.  After each
time point, an NMR spectrum was taken.  The reduction of the benzyl peak (4.1 ppm)
and the appearance of an aldehyde peak (10.15 ppm) were the two specific peaks that
were analyzed during the photolysis experiments.
After four and a half minutes of irradiation, the sample was purified by Prep-TLC.
The TLC was developed using a 50:50 ethyl acetate and hexane solvent system.  Three
ultravoilet active bands were seen at Rfs of 0.77, 0.56, and baseline.  Bands were
removed using a razor blade and the product was extracted out of the silica using ethyl
acetate.  Samples were then analyzed by ESI ionization, quadrupole mass spectrometry
and gas chromatography – mass spectrometry (GC-MS).  The Hewlett Packard GC-MS
was equipped with a HP-5HS column (30 m X 0.25 mm ) and a 5970 mass selective
detector.  Reference (37) was used as a guide to establish a protocol for performing and
analyzing peptide photolysis experiments.
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2.5.3 In vitro protein incorporation – base hydrolysis:
In vitro transcription was carried out using Promega rabbit reticulocyte lysate
translation system according to manufacturer’s protocol and reference (20).  The
following reagents were combined and incubated at 30oC for 2 hours – 8.75 ml of lysate
mix, 0.25 ml Amino acid mix, 0.25 ml RNAse inhibitor, 1.75 ml water, 0.5 ml of mRNA (1
mg/ml for suppression experiments and 0.3 mg/ml for wildtype RNA), and either 1 ml of
water or 1 ml of tRNA (1 mg/ml).   Protein was then kept at –80oC until further use.
Samples were made by taking 5 ml of in vitro translation mix and adding 5 ml of
4% SDS.  This mixture was subdivided into two samples (untreated and base treated
samples).  Untreated samples were further dissolved in 1 ml of 10% SDS and then
incubated for 1.5 hours at room temperature.  After incubation, 1 ml of 10% SDS, 7 ml of
water, and 14 ml of 2 X SDS loading buffer (100 mM Tris-Cl pH 6.8, 4% SDS, 0.2%
bromophenol blue, 20% glycerol) were added.   Base treated samples were diluted with 2
ml of concentrated NH4OH with 10% SDS, and the samples were incubated for 1.5 hours
at room temperature.   The reaction was then quenched with 1 ml of 30% acetic acid in
10% SDS.  The samples were further diluted with 7 ml of water and 14 ml of 2 X SDS
loading buffer.  Samples (5 ml) were loaded onto 10-12 % Tris-Cl gels. After SDS-
PAGE, the gels were transferred to nitrocellulose.  The nitrocellulose paper was then
blotted using a mouse anti-HA antibody and subsequently treated with a goat anti-mouse
secondary antibody conjugated to horseradish-peroxidase for detection by
chemiluminescence.
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2.5.4 In vitro protein incorporation – photolysis:
Protein was synthesized according to the procedure described above (2.5.3) .    10
– 15 ml of sample was irradiated individually using the arc lamp (1000 W xenon arc lamp
(Oriel) operating at 400 W equipped with WG-335 and UG-11 filters).  For irradiations
over ten minutes, eppendorfs were kept in water.  In experiments run with protein
purified using the spin-filter, the scale of the transcription reaction described above
(2.5.3) was tripled.
For the tripled transcription reactions, Ni2+ purification was performed by first
taking 90 ml of Ni2+-NTA beads (Qiagen) and washing with 270 ml of buffer A (100 mM
sodium phosphate pH 7.8, 2% SDS) three times.  The beads were then added to the
transcription reaction with 180 ml of buffer A.   The beads were incubated with the
transcription reaction for three hours at 4oC.  The beads were then washed 4 X 270 ml of 5
mM imidazole in buffer A.  The protein was then eluted off the beads with 150 ml of 300
mM imidazole in buffer A.  This sample solution (a subunit in buffer A with 300 mM
imidazole) was used in a few photolysis experiments.  However based on observations
discussed in the results section, removal of the imidazole is essential in the success of the
photolysis experiments.  
Ultra free – MC Millipore centrifugal filter devices (30 kD) (spin-filter) were used
to separate protein from imidazole.  Spin-filters were blocked with 300 ml of 1 X BSA in
buffer B (100 mM sodium phosphate pH 7.4, 2% SDS)  for 2 hours at room temperature
before protein was applied to the filter.  The filter was then washed three times with 300
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ml of buffer B.  Eluted protein from Ni2+ bead purification (75 ml to 150 ml) was diluted
with  200 ml of buffer B and then applied to the spin-filter.  The sample was diluted three
times with 200 ml of buffer B.  The sample was then centrifuged down to the desired
volume, usually between 40-80 ml depending how much eluted protein was added to the
spin-filter.   The purified sample was removed from the spin-filter and used in photolysis
experiments.
2.5.5 In vivo suppression of NBSeOH:
The site-directed mutagenesis of Shaker B TAG mutants, gene construction, and
synthesis of suppressor tRNA, and ligation of aminoacyl-dCA to tRNA have been
described previously (1, 29, 30).  Constructs used in Pam England’s ShB suppression
experiments were used for NBSeOH in vivo suppression experiments (1).  Plasmid DNAs
were linearized with Not1, and mRNA was transcribed using the Ambion T7
mMESSAGE mMACHINE kit.
Oocytes from Xenopus laevis were isolated and treated according to published
procedures (31, 45).  Each oocyte was microinjected (50 nl) with a 1:1 mixture of mRNA
for the ShB L47TAG construct (0.04 ng/nl) and tRNA (1 mg/ml).  The tRNA was either
tRNA amino-acylated to nitroveratryloxycarbonyl (NVOC) protected leucine (Leu), N-
pent-4-enoyl protected 2-nitrophenylglycine (Npg), or unprotected NBSeOH.  In
addition, un-acylated tRNA (dCA control) was also injected with ShB L47TAG mRNA.
The tRNA-Leu and tRNA-Npg were deprotected prior to injection according to published
procedures  (1, 31).  In most experiments, little to no current was seen with dCA controls.
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Electrophysiology
Whole cell currents from oocytes were measured using a Geneclamp 500
amplifier (Axon Instruments) in the 2-electrode voltage-clamp configuration.  Current
and voltage electrodes were filled with 3 M KCl to yield resistances ranging from 0.5 to 1
MW.   The holding potential was either –80 mV or –40 mV.  The currents from ShB
expressing oocytes were measured during depolarizing jumps from the holding potential
to various test potentials between –60 mV to +60 mV in 20 mV jumps.   Leakage
currents were subtracted using P/4 procedure (1).  The oocytes were continuously bathed
in ND-96 calcium free bath solution (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM
HEPES (pH 7.5)).
The oocytes were irradiated on the electrophysiology rig.  The apparatus used to
irradiate samples has been reported previously (46).  Light from 300-W Hg arc lamp was
filtered through a Schott UG11 filter to provide 300-350 nm light.  The light was focused
through  50 mm quartz lens (Oriel) onto a liquid light guide (Oriel, 1 m long, 3mm
diameter) connected to the recording chamber.  The end of the light guide contacted a
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